Press Release

Sudair Pharma Selects IQVIA's Orchestrated Customer Engagement Platform to Improve HCP Engagement

Oct 04, 2021

SAUDI ARABIA – (October 7, 2021) - IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that Sudair Pharma, a leading pharmaceutical company in Saudi Arabia, has selected IQVIA Technologies’ Orchestrated Customer Engagement (OCE) platform for deployment in Saudi Arabia, with future plans to deploy it regionally.

“We are pleased to partner with IQVIA to rollout it’s OCE platform in Saudi Arabia,” said Dr.Yasser AlObaida, CEO of Sudair Pharma. “During the last few years, the digital transformation in the pharmaceutical sector has evolved, requiring more collaboration between pharmaceutical firms and a broader set of healthcare providers. Sudair Pharma selected OCE due to its unique capabilities that will help ensure well-organized scientific communication to a broad set of healthcare stakeholders that ultimately benefit our patients.”

IQVIA OCE for advanced customer engagement breaks down silos by seamlessly connecting sales, account management, marketing and other functions to enhance the customer experience, strengthen relationships, and drive performance. OCE is built on best-in-class industry platforms, including Salesforce, MuleSoft, Heroku, and Box. OCE is equipped with unique capabilities that provide AI-enabled recommendations, fluid integration with other data and applications to deliver smarter, coordinated engagements with healthcare professionals.

“We are excited to onboard Sudair Pharma on our OCE platform,” said Ravi Akella, Sr Director, Tech Solutions, Middle East. “With Covid-19, Pharma companies are having to look for creative ways of engaging healthcare professionals and OCE is the perfect platform for bringing personalized engagement with HCPs.”

Sudair Pharma joins more than 140 other life sciences customers that have selected IQVIA OCE’s innovative solutions to address market momentum and the need for innovative platforms to advance customer engagement.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 74,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

About Sudair Pharma

Sudair Pharma is a Saudi based company, established in 2014 for the purpose of building an advanced pharmaceutical manufacturing complex to combat cancer , chronic and life-threatening diseases by establishing and localizing an Advanced Pharmaceutical-Biologics Industrial Group (APBIG) to improve healthcare provision and reach to the latest pharmaceuticals in Saudi Arabia and MENA region through building a professional team, international partnerships and affiliations to fulfill the unmet needs in the pharmaceutical sector in the region.

Contact Us